PRKG1 and ischemia: The protective effect of DETA/NO was eliminated when the hearts were pre-perfused with PKG inhibitor KT2358: the level of ischemia-induced caspase activation in this group (KT2358 and DETA/NO treatment before ischemia) was as high as in ischemic group (Fig. 6A).